Department of laboratory sciences, Sirjan School of Medical Sciences, Sirjan, Iran.
Department of Animal Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.
Int J Biol Macromol. 2021 Oct 1;188:740-750. doi: 10.1016/j.ijbiomac.2021.08.076. Epub 2021 Aug 14.
The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines.
全球遭受 COVID-19 疾病的困扰已超过一年,其死亡率仍然很高。除了需要通过使用口罩和保持社交距离等非药物措施尽量减少病毒传播外,全世界还在努力开发各种疫苗来预防这种疾病。到目前为止,几种疫苗已在各个阶段的临床试验中达到了安全性和有效性的最后阶段,其中一些,如 Moderna/NIAID 和 BioNTech/Pfizer,报告了非常高的安全性和保护率。重要的是,比较不同的疫苗并不容易,因为没有衡量中和作用的既定标准。在这项研究中,我们回顾了 COVID-19 疫苗的常见平台,并尝试呈现这些疫苗的最新有效性报告。